MECOTEC Group launches mobile hybrid container for vaccine transport and storage

First Mobile Hybrid Container Solution made by MECOTEC with an active deep cooling technology for transport, storage and distribution of COVID-19-Vaccines down to – 80°C / -112 °F. (PRNewsfoto/MECOTEC GmbH)

BITTERFELD-WOLFEN, Germany — Vaccine manufacturers, transport and storage providers are facing major challenges in the fight against the coronavirus. MECOTEC Group has announced a complete-one-stop-solution consisting of: 1. Deep-freeze cooling + 2. Transport + 3. Storage & distribution of the vaccines: Immediately after production, the vaccine is frozen in a deep cold storage and then loaded into a container, transported afterwards safely to the distribution center at constant temperatures down to – 80°C / -112 °F. On site, the transport container then functions as a storage and distribution center. It is supplied via a three-phase power connection with 400V.

“Our many years of experience in the field of cooling technology made it possible within a very short timeframe to develop the transport, storage and distribution container,” said Jan Hüneburg, Managing Director at COOLANT, the industrial division of MECOTEC, in a prepared statement.

“We are pleased that today we can present our Mobile Hybrid Container Solution for the transport and storage of Covid-19-Vaccines globally,” said the CEO of MECOTEC Group Enrico Klauer. “Since our system is based on an active deep freezing technology, it does not require dry ice for cooling which makes it also suitable for safe carriage by air.”

The complete solution developed by the MECOTEC Group can be used worldwide.